Warning Issued Over Dangerous Erectile Dysfunction Drug

The TGA has identified Ziyinzhuangyang tablets as a health risk due to undeclared sildenafil content.

The Therapeutic Goods Administration (TGA) has warned against the use of Ziyinzhuangyang tablets, which are marketed for erectile dysfunction.
Testing revealed these tablets contain sildenafil, a prescription-only substance that can cause serious side effects.
Sildenafil can dangerously lower blood pressure when combined with nitrates, often prescribed for heart-related conditions.
The tablets were purchased online from overseas and have not been approved by the TGA for safety or efficacy.
Consumers are advised to dispose of the tablets safely and consult healthcare providers if they have health concerns.